MedTrace Logo

Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Prospective Observational Study

NCT07604480 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2026-05-22

No results posted yet for this study

Summary

This prospective observational study evaluated the safety and efficacy of a remimazolam-propofol combination sedation protocol in adult patients undergoing elective gastrointestinal endoscopy at a tertiary care centre in Romania. The primary outcome was procedural completion. Secondary outcomes included time to sedation onset, recovery time, discharge readiness, total sedative doses administered, and incidence of adverse events including cardiovascular and respiratory complications.

Conditions

  • Procedural Sedation
  • Gastrointestinal Endoscopy

Sponsors & Collaborators

  • University of Medicine and Pharmacy "Victor Babes" Timisoara

    lead OTHER

Principal Investigators

  • Ovidiu Bedreag, MD, PhD · Victor Babes University of Medicine and Pharmacy Timisoara

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-03-15
Completion
2025-03-15

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07604480 on ClinicalTrials.gov